WDR77 and thyroid cancer: Functional studies of WDR77 variants in PTC patients showed that these variants impair formation of the complex WDR77-PRMT5, resulting in reduced H4R3me2 in patients, and knockdown of WDR77 resulted in increased growth of thyroid cancer cells (10).